High Tech and High Touch (HT2): Transforming patient engagement through portal technology at the bedside
高科技和高接触 (HT2):通过床边门户技术改变患者参与度
基本信息
- 批准号:9322387
- 负责人:
- 金额:$ 23.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-30 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The appropriate use of technology to actively engage with patients who suffer from multiple chronic conditions, called multimorbidity, is one of the frontiers of both research and practice. For multimorbid patients, engagement in disease management activities is particularly critical, and evidence shows that enhanced patient self-management can lead to better control of chronic illness. One tool finding increasing use is the patient portal, and its pervasiveness is supported by virtue of its role as a component of the Meaningful Use criteria. A patient portal is a tethered personal health record (tPHR) that links to
the patient's electronic health record, facilitating communication and engagement activities with healthcare providers. While most tPHRs have been focused on outpatient activities, a new class of tools focused on the inpatient experience has begun deployment in 2014. In response, this study supports the conduct of the first, large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage. We aim to study how access to a patient portal tailored to the inpatient stay can improve patient experience and increase patient engagement by improving patients' perception of the process of care while in the hospital (patient experience), increasing patients' self-efficay for managing their chronic conditions (patient engagement), and facilitating use of a patient portal for care management activities after discharge (patient engagement). The study site is a world-class healthcare facility with the ability to provide access to a patient portal designed specifically for the inpatient experience, bridging to outside the hospital after discharge. Currently, this inpatient technology exists in only one other hospital in the US, but we expect that as inpatient PHRs become more readily available, the need for clarity on this issue will only increase. Our evaluation is a mixed-methods design consisting of primary data collection through surveys and interviews throughout the study period, and secondary data collection from the electronic health record and health system metadata. This study will offer insight into a potentially important mechanism to facilitate patient self-management.
描述(由申请人提供):适当使用技术积极与患有多种慢性疾病(称为多发病)的患者接触,是研究和实践的前沿之一。对于多病患者,参与疾病管理活动尤为重要,有证据表明,加强患者自我管理可以更好地控制慢性疾病。患者门户网站是一个越来越多使用的工具,其普及性得益于其作为有意义使用标准组成部分的作用。患者门户是一个绑定的个人健康记录(tPHR),
患者的电子健康记录,促进与医疗保健提供者的沟通和参与活动。虽然大多数tPHR一直专注于门诊活动,但2014年已开始部署一类专注于住院体验的新工具。作为回应,本研究支持进行第一项大规模随机对照试验(RCT),研究基于平板电脑的住院患者门户网站的影响和使用,并将其嵌入更大规模的混合方法研究中,以检查患者体验和结局的变化,以及随后的门诊患者门户网站使用情况。我们的目标是研究如何访问定制的住院患者门户网站可以改善患者的体验,并通过改善患者的护理过程中,而在医院(患者体验),提高患者的自我效能管理他们的慢性疾病(患者参与),并促进出院后的护理管理活动(患者参与)的患者门户网站,提高患者的参与度。该研究中心是一家世界级的医疗机构,能够提供专为住院患者体验设计的患者门户网站,在出院后与医院外建立联系。目前,这种住院技术只存在于美国的另一家医院,但我们预计,随着住院PHR变得越来越容易获得,对这个问题的澄清需求只会增加。我们的评估是一种混合方法设计,包括在整个研究期间通过调查和访谈收集的主要数据,以及从电子健康记录和卫生系统元数据收集的次要数据。这项研究将提供一个潜在的重要机制,以促进患者自我管理的洞察力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Scheck McAlearney其他文献
Impact of an embedded onco-palliative care clinic on urine drug testing in thoracic oncology
- DOI:
10.1007/s00520-025-09622-3 - 发表时间:
2025-06-16 - 期刊:
- 影响因子:3.000
- 作者:
Julia L. Agne;Amanda V. Gusovsky Chevalier;Jason A. Benedict;Nida Khan;Maureen Saphire;Pooja Kumar;Madison M. Grogan;Justin Kullgren;Sachin S. Kale;Jack Stevens;Ann Scheck McAlearney;Carolyn J. Presley - 通讯作者:
Carolyn J. Presley
High-Performance Work Practices in CLABSI Prevention Interventions : Executive Summary
CLABSI 预防干预措施中的高绩效工作实践:执行摘要
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Ann Scheck McAlearney - 通讯作者:
Ann Scheck McAlearney
Interventions to Improve Surveillance for Hepatocellular Carcinoma in High-Risk Patients: A Scoping Review
- DOI:
10.1007/s12029-023-00944-1 - 发表时间:
2023-06-16 - 期刊:
- 影响因子:1.600
- 作者:
Eliza W. Beal;Molly McNamara;Mackenzie Owen;Ann Scheck McAlearney;Allan Tsung - 通讯作者:
Allan Tsung
Care for patients with cancer and substance use disorders: a qualitative study of oncology team experiences
- DOI:
10.1007/s00520-025-09181-7 - 发表时间:
2025-02-04 - 期刊:
- 影响因子:3.000
- 作者:
Sachin S. Kale;Laura J. Rush;Jennifer L. Eramo;Mireille Bitangacha;Sadie Chen;Devon K. Check;Katie Fitzgerald Jones;Jessica Merlin;Ann Scheck McAlearney - 通讯作者:
Ann Scheck McAlearney
Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review
- DOI:
10.1007/s12029-022-00851-x - 发表时间:
2022-07-26 - 期刊:
- 影响因子:1.600
- 作者:
Eliza W. Beal;Mackenzie Owen;Molly McNamara;Ann Scheck McAlearney;Allan Tsung - 通讯作者:
Allan Tsung
Ann Scheck McAlearney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann Scheck McAlearney', 18)}}的其他基金
Project 3: Responding to Changing Serological and Viral Information around COVID-19 (RESPOND)
项目 3:应对围绕 COVID-19 不断变化的血清学和病毒信息(RESPOND)
- 批准号:
10222412 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
血清学检测中心以改善大流行性 COVID-19 的结果 (STOP-COVID)
- 批准号:
10688381 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
血清学检测中心以改善大流行性 COVID-19 的结果 (STOP-COVID)
- 批准号:
10222406 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
血清学检测中心以改善大流行性 COVID-19 的结果 (STOP-COVID)
- 批准号:
10706723 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID)
血清学检测中心以改善大流行性 COVID-19 的结果 (STOP-COVID)
- 批准号:
10855013 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Project 3: Responding to Changing Serological and Viral Information around COVID-19 (RESPOND)
项目 3:应对围绕 COVID-19 不断变化的血清学和病毒信息(RESPOND)
- 批准号:
10688397 - 财政年份:2020
- 资助金额:
$ 23.74万 - 项目类别:
Searching for Management Approaches to Reduce HAI Transmission (SMART)
寻找减少医院感染传播的管理方法(SMART)
- 批准号:
10133041 - 财政年份:2017
- 资助金额:
$ 23.74万 - 项目类别:
相似国自然基金
“Touch-and-go”策略下低温厌氧消化胞外电子传递机制研究
- 批准号:22308115
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
血管周围脂肪组织雌激素改善No-Touch技术静脉桥通畅率的机制研究
- 批准号:82370401
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
In-Touch: Implementation of a person-centered palliative care iNtervention To imprOve comfort, QUality of Life and social engagement of people with advanced dementia in Care Homes
In-Touch:实施以人为本的姑息治疗干预措施,以提高护理院中晚期痴呆症患者的舒适度、生活质量和社会参与度
- 批准号:
10102690 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
EU-Funded
In-Touch: Implementation of a person-centered palliative care iNtervention To imprOve comfort, QUality of Life and social engagement of people with advanced dementia in Care Homes
In-Touch:实施以人为本的姑息治疗干预措施,以提高护理院中晚期痴呆症患者的舒适度、生活质量和社会参与度
- 批准号:
10108568 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
EU-Funded
Touch and Tension: Molecular Determinants of Human Mechanosensation
触摸和张力:人类机械感觉的分子决定因素
- 批准号:
DP240102511 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Discovery Projects
EAGER: Flexible and compressible e-Skin integrated with soft magnetic coil based ultra-thin actuator and touch sensor for robotics applications
EAGER:灵活且可压缩的电子皮肤与基于软磁线圈的超薄执行器和触摸传感器集成,适用于机器人应用
- 批准号:
2337074 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Standard Grant
Tracing the brain mechanisms of affective touch.
追踪情感触摸的大脑机制。
- 批准号:
23K19678 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
EAGER: Prototyping Touch with FLS-Matter
EAGER:使用 FLS-Matter 制作触摸原型
- 批准号:
2232382 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Standard Grant
Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy
仿生乳房项目:神经假体可恢复触觉并减轻乳房切除术后的慢性疼痛
- 批准号:
10753314 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
KoALX - Development of a closed-loop sensory 'touch' feedback system and haptic sleeve for upper limb prothesis
KoALX - 开发用于上肢假肢的闭环感觉“触摸”反馈系统和触觉套筒
- 批准号:
10057993 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Collaborative R&D
Development of Human to Human (H2H) communication platform that creates personalised call to action videos with a human touch
开发人与人 (H2H) 交流平台,创建具有人性化的个性化号召性用语视频
- 批准号:
10046849 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Collaborative R&D
WITHIN TOUCHING DISTANCE R&D: Scaling empathy through patient-centred Affective Touch
在接触距离内 R
- 批准号:
10056442 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Grant for R&D














{{item.name}}会员




